CNTG Stock Price, Chart, Stats & News

Centogene N.V.
Save
9.42M
Market cap
–
Current P/E
–
Forward P/E
CNTG chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 35.54% |
Operating margin | -61.11% |
Pretax margin | -72.62% |
Net margin | -73.21% |
Effective tax rate | -0.81% |
ROA | -46.05% |
ROE | 397.65% |
D/E | -3.18x |
Interest coverage ratio | -3.62x |
CNTG valuation
P/E | – |
P/S | 0.17x |
P/B | -0.31x |
P/CF | -0.25x |
P/FCF | -0.24x |
P/OCF | -0.25x |
PEG | -0.00x |
EV multiple | 2.78x |
About
Centogene N. V., along with its affiliates, operates globally with a primary focus on rare diseases. The company excels at converting diverse real-world data—spanning clinical, genetic, and other sources—into practical insights for patients, medical professionals, and pharmaceutical enterprises worldwide.
Similar securities
Based on sector and market capitalization
Report issue











